NCT06757712 Periodization Resistance Training on Quality of Life in Females With Hypothyroidism
| NCT ID | NCT06757712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Hypothyroidism |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2025-01-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be conducted to compare between the effect of nonlinear and linear periodized training on quality of life in females with hypothyroidism.
Eligibility Criteria
Inclusion Criteria: * Be controlled hypothyroidism (TSH level within 0.5 - 4.5 mU/L) * Be ranged from 35 to 45 years * Female patients * Body Mass Index 30-34.9 kg/m2 . * triglyceride-glucose (TyG) index \> 4.5 Exclusion Criteria: * history of pulmonary disease * Patients with uncontrolled coronary or cerebrovascular disease * Those who underwent musculoskeletal surgery within the previous year * Recent history of lower and upper limb fracture , hip and shoulder dislocation. * Cognitive impaired patients * Patients with history of epilepsy * Patients who participating in any other exercise program
Contact & Investigator
Nesreen Gharib Mohamed Elnahas, PhD
STUDY CHAIR
Professor, Cairo university
Frequently Asked Questions
Who can join the NCT06757712 clinical trial?
This trial is open to female participants only, aged 35 Years or older, up to 45 Years, studying Hypothyroidism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06757712 currently recruiting?
Yes, NCT06757712 is actively recruiting participants. Contact the research team at dmonamahmoud925@gmail.com for enrollment information.
Where is the NCT06757712 trial being conducted?
This trial is being conducted at Suez, Egypt.
Who is sponsoring the NCT06757712 clinical trial?
NCT06757712 is sponsored by Cairo University. The principal investigator is Nesreen Gharib Mohamed Elnahas, PhD at Professor, Cairo university. The trial plans to enroll 75 participants.